{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"34.020","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"299,807,117","primaryexch":"香港交易所","ric":"1513.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":2.2395,"inline_upper_strike_price":"","sedol":"BJ34614","am":"32.38","iv":"","ew_strike":"","as":"33.720","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"33.700","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"24.850","shares_issued_date":"2025年9月25日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"朱保國","underlying_ric":"000513.SZ","hi52":"41.850","issuer_name":"麗珠醫藥集團股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"3.56","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"33.300","mkt_cap":"10.10","f_aum_hkd":null,"ew_sub_per_to":"","ls":"33.700","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.380","aum":"","issued_shares_class_B":null,"vo":"960.85","secondary_listing_flag":false,"listing_date":"2014年1月16日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"麗珠醫藥集團股份有限公司 - H股","nm_s":"麗珠醫藥","sym":"1513","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"麗珠醫藥集團股份有限公司是一家主要從事醫藥產品的研發、生產及銷售業務的中國公司。該公司的主要業務包括化學製劑、生物製品、原料藥及中間體、中藥製劑、診斷試劑和設備以及商業發展和職能管理。該公司的主要產品品牌包括“壹麗安”（艾普拉唑腸溶片及註射用艾普拉唑鈉）、“麗珠得樂”（枸櫞酸鉍鉀）系列產品、“麗倍樂”（雷貝拉唑鈉腸溶膠囊）、“維三聯”（枸櫞酸鉍鉀片/替硝唑片/克拉霉素片）、“貝依”（註射用醋酸亮丙瑞林微球）、“麗申寶”（註射用尿促卵泡素）、“樂寶得”（註射用尿促性素）、“麗福康”（註射用伏立康唑）等。該公司主要在中國國內和海外市場開展業務。","op":"34.020","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國廣東省<br/>珠海市金灣區<br/>創業北路38號<br/>總部大樓（郵編：519090）","pc":"-1.12","days_to_expiry":null,"underlying_code":null,"pe":"14.22","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"34.080","isin":"CNE100001QV5","moneyness":""}},"qid":"1759074267395"}
